Resource Center
Browse industry research articles, publications, and other important resources.
-
browse
By Topic
By Disease Area
-
Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-Stakeholder Consensus
Posted November 16, 2017 by Rob Conley, MD, JD, MPH ,Jennifer Al Naber, MS, MSPH ,Donna Messner, PhD {categories}in{category_name}, {/categories}
Conley RB, ', Al Naber J, Messner, DA, et al. Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-Stakeholder Consensus. Cell 2017;171(5):982-986. doi.org/10.1016/j.cell.2017.10.032
-
Best Practices for the Design, Implementation, Analysis, and Reporting of Oncology Trials with High Rates of Treatment Switching
Posted October 7, 2016 by Rob Conley, MD, JD, MPH ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
GPC released a report that provides guidance for researchers who lead oncology drug trials that may involve substantial treatment switching. Treatment switching most often occurs when a patient moves from the control to the experimental group during a clinical trial ' for example, because the patient 's disease has progressed and they want to try the experimental treatment.
-
A Multi-stakeholder Agenda to Advance Enhanced Recovery for U.S. Surgical Patients
Posted October 9, 2014 by Rachael Moloney, MHS ,Rob Conley, MD, JD, MPH ,Donna Messner, PhD ,Sean Tunis, MD, MSc {categories}in{category_name}, {/categories}
This white paper builds upon earlier work, including a multi-stakeholder forum in which participants discussed potential challenges and opportunities to accelerate the adoption of Enhanced Recovery Protocols (ERPs) in the U.S. The white paper shares key insights from the forum regarding potential steps to overcome barriers, and proposes a roadmap to accelerate the adoption of ERPs in the U.S.